Clinical Trials Browser

HER2-positive Breast Cancer × Cyclophosphamide × 30 days × Clear all

NCT07635342 2026-06-09

Pyrotinib Plus Trastuzumab and Chemotherapy for HER2-Positive Early Breast Cancer

Phase 2 Recruiting

HER2-positive Breast Cancer